adMare BioInnovations
adMare BioInnovations is Canada's national life sciences company creation engine, operating Montreal and Vancouver Innovation Centres, the Tx Accelerator, and talent programs to build, fund, and scale early-stage biotech ventures for the Canadian ecosystem.
- Company typePrivate
- Founded2005
- HeadquartersVancouver, Canada
- Headcount—
- GTM typeB2B
- OfferingServices
What adMare BioInnovations does
adMare BioInnovations is a Vancouver-headquartered, privately held Canadian life sciences company creation engine that builds early-stage biotechnology ventures, operates shared R&D infrastructure, and develops industry-ready scientific and executive talent. Founded as the successor to CDRD (Centre for Drug Research and Development, 2005) and re-launched under the adMare brand in 2019, the organization reports helping create 39 companies that have collectively attracted $2.5 billion in risk capital, achieved $5.8 billion in combined value, and generated approximately 1,000 jobs in Canada.
The core product surface consists of three integrated layers. First, two multi-tenant Innovation Centres in Montreal and Vancouver (with the April 2026 opening of the M4 Innovation Centre adding 30,000 sq ft of new capacity to a base of more than 200,000 sq ft) provide move-in-ready wet-lab and office space, shared services such as analytical chemistry and in vivo pharmacology, and a collaborative ecosystem currently housing 29 resident companies and 370+ employed life sciences professionals. Second, the Tx Accelerator offers preclinical-stage ventures integrated scientific, regulatory, IP, and business development support in exchange for equity-linked financing (convertible notes or SAFEs), supplemented by co-accelerator programs with MaRS Discovery District and OBIO and the AbbVie Biotech Innovators Award for Quebec-based startups. Third, the talent stack (adMare Executive Institute, BIS Program, Experiential Learning) and the adMare Community digital platform (3,500+ life sciences professionals) complete a national platform.
The business model is that of a non-profit life sciences development corporation rather than a commercial enterprise: revenue is reinvested into the Canadian ecosystem, services to portfolio companies are delivered through equity-linked instruments rather than fees, and Innovation Centre lab/office space is offered at subsidized rates. The organization is funded through a combination of government, industry, and philanthropic sources, with no parent company, public listing, or VC/PE ownership identified in the source data. Go-to-market is primarily direct and partnership-driven — engaging academic researchers, entrepreneurs, and institutional investors — with no traditional product marketing or paid acquisition channels.
adMare BioInnovations firmographics
Firmographics- Name
- adMare BioInnovations
- Legal name
- adMare BioInnovations
- Website
- https://admarebio.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Short description
- adMare BioInnovations is Canada's national life sciences company creation engine, operating Montreal and Vancouver Innovation Centres, the Tx Accelerator, and talent programs to build, fund, and scale early-stage biotech ventures for the Canadian ecosystem.
- Ownership category
- akta.pro rank
adMare BioInnovations industry classification
Industry- Product category
- Biotech Venture Development & Incubation
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF)
- akta.pro secondary industries
- Makerspace, Innovation Lab & Fab Lab Operations (Tools, Safety, Programming) (EDAEAGAI), Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)
Keywords
Where adMare BioInnovations is headquartered
LocationHeadquarters
- HQ city
- Vancouver
- HQ country
- Canada
- HQ region
- North America
Offices3 records
Markets served
adMare BioInnovations business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Infrastructure, Personnel, Operations, Technology or R&D, Marketing or Sales
Distribution channels2 records
Marketing channels8 records
adMare BioInnovations product offering
Product offeringCore offering
adMare BioInnovations operates as Canada's life sciences company creation engine. It provides specialized R&D infrastructure (Innovation Centres in Montreal and Vancouver with over 200,000 sq ft of turnkey lab space), seed capital through equity-based instruments, and commercial and scientific expertise to build investable Canadian life sciences companies. The organization also delivers structured accelerator programs (Tx Accelerator), executive leadership training (Executive Institute), and industry skills programs (BIS Program) to support the Canadian life sciences ecosystem.
Product overview
adMare BioInnovations is Canada's life sciences company creation engine, operating as a multi-service organization rather than a single unified product. The core offering centers on two Innovation Centres (Montreal and Vancouver) providing over 200,000 square feet of turnkey laboratory and office infrastructure for life sciences companies. The Tx Accelerator program supports early-stage ventures with integrated services including scientific guidance, coaching, and business development in exchange for equity financing. Supporting talent development functions include the Executive Institute (leadership training), BIS Program (industry skills), and Experiential Learning. The adMare Community digital platform connects over 2,000 life sciences professionals. Additionally, the AbbVie Biotech Innovators Award partnership provides selected Quebec startups with lab space and mentorship.
Differentiator
Problem solved
Functional benefit
Brands
- Tx Accelerator: adMare supports Canadian start-ups involved in the development of new therapies at the preclinical stage through its Accelerator Program.
- M4 Innovation Centre
- AbbVie Biotech Innovators Award
- adMare Community
Products and services
- Innovation Centres
Quantifiable outcome
- 39 companies created with $2.5B risk capital attracted and $5.8B combined value
- +3 more outcomes
Companies that use adMare BioInnovations
Customer profileSegments3 records
Ideal customer profiles3 records
adMare BioInnovations technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
adMare BioInnovations partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- VoxCell BioInnovationcoreVoxCell BioInnovation and adMare BioInnovations entered a research partnership to validate a novel antibody-based immune-modulating therapy using VoxCell's human-relevant vascularized cancer tissue models. The collaboration applies perfusable, immune-competent 3D bioprinted cancer tissue models for preclinical evaluation of next-generation oncology biologics, supporting FDA's push toward more predictive, human-relevant testing and reduced reliance on animal models.
- AbbViecoreAbbVie and adMare BioInnovations jointly deliver the AbbVie Biotech Innovators Award, a prize designed to foster innovation and support growth in Quebec's life sciences sector. The award provides winning companies with one year of laboratory and office space at the adMare Innovation Centre in Montreal, access to shared equipment and services, and mentorship from AbbVie's scientific and business leaders. The award targets early-stage biotechnology companies with potential for transformational therapies in AbbVie's therapeutic focus areas including immunology, oncology, neuroscience, and aesthetics.
- Queen's UniversitycoreadMare collaborated with Queen's University researchers including Dr. Martin Petkovich and Dr. Jacob Rullo to advance retinoic acid biology research, resulting in the creation of 26therapeutics Inc. for dry eye disease treatment.
- MaRS Discovery DistrictcoreThe Mars-adMare Accelerator Experts program brings together mentorship and expertise from both organizations to support therapeutic startup development in Canada's life sciences ecosystem.
- OBIO (Ontario Bioscience Innovation Organization)coreadMare partners with OBIO for the MaRS-adMare Therapeutic Accelerator, supporting biotech innovation across Canada through shared expertise and network access.
Scale indicators10 records
Recent moves7 records
Expansion highlights6 records
adMare BioInnovations competitors and assessment
Company assessmentDirect peers
- MBC BioLabs: San Francisco Bay Area life sciences incubator offering turnkey lab space and shared equipment to early-stage biotech startups. Operates a comparable rental-based model with similar entrepreneur-focused programming.
- BioBAT Innovation Center: New York City life sciences incubator providing wet-lab and office space to early-stage biotech companies within a multi-tenant model. Direct structural analog to adMare's Innovation Centres with similar tenant and shared-services approach.
- LabCentral: Non-profit life sciences incubator in Cambridge, MA operating shared lab facilities and accelerator programs for early-stage biotech startups. Closest analog to adMare's Innovation Centre model, with move-in-ready wet labs and shared scientific services.
- Alexandria LaunchLabs: Alexandria Real Estate's life sciences startup platform offering turnkey lab space, equipment, and entrepreneurship programming across multiple US sites. Direct competitor in the premium life sciences incubator space market.
- BioEnterprise: Cleveland-based nonprofit bioscience business accelerator that advises and capitalizes healthcare and biotech startups. Runs a portfolio approach similar to adMare with mentoring, capital, and ecosystem development support.
- JLABS (Johnson & Johnson Innovation): Global network of life sciences incubators operated by J&J Innovation, providing no-strings-attached lab space and mentorship to early-stage biotech. Direct competitor in the biotech incubation category with similar shared lab and accelerator offerings.
- BioGenerator: St. Louis-based nonprofit that creates and invests in bioscience companies from university research, providing lab space, seed capital, and company formation expertise. Closely mirrors adMare's "company creation engine" model.
Broad incumbents
- MaRS Discovery District: Toronto-based innovation hub supporting science, health, and tech ventures across broader categories, including a partnership program (MaRS-adMare Accelerator) with adMare. Overlapping mission of building Canadian innovation capacity but with a broader (non-biotech-exclusive) scope.
- Ontario Bioscience Innovation Organization (OBIO): Toronto-based nonprofit industry association supporting Ontario's bioscience sector through ecosystem development. Partners with adMare on the MaRS-adMare Therapeutic Accelerator and pursues adjacent ecosystem-building objectives in Canada.
Regional players
- Francis Crick Institute: London-based biomedical research institute with strong industry partnership and commercialization programming for translating research into therapeutic ventures. Comparable translational and talent-development mission, anchored in the UK rather than Canada.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
adMare BioInnovations social profiles
Digital presenceadMare BioInnovations financial estimates
Financial estimateRevenue estimate
Valuation estimate
adMare BioInnovations leadership team
Management profileNumber of profiles
Profiles6 records
adMare BioInnovations funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
adMare BioInnovations M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about adMare BioInnovations
What does adMare BioInnovations do?
adMare BioInnovations operates as Canada's life sciences company creation engine. It provides specialized R&D infrastructure (Innovation Centres in Montreal and Vancouver with over 200,000 sq ft of turnkey lab space), seed capital through equity-based instruments, and commercial and scientific expertise to build investable Canadian life sciences companies. The organization also delivers structured accelerator programs (Tx Accelerator), executive leadership training (Executive Institute), and industry skills programs (BIS Program) to support the Canadian life sciences ecosystem.
Is adMare BioInnovations a public or private company?
adMare BioInnovations is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was adMare BioInnovations founded?
adMare BioInnovations was founded in 2005.
Where is adMare BioInnovations based?
adMare BioInnovations is headquartered in Vancouver, Canada, in the North America region.
Who are adMare BioInnovations's main competitors?
Direct peers on record are MBC BioLabs, BioBAT Innovation Center, LabCentral, Alexandria LaunchLabs, BioEnterprise, JLABS (Johnson & Johnson Innovation) and BioGenerator. Broad incumbents are MaRS Discovery District and Ontario Bioscience Innovation Organization (OBIO). Francis Crick Institute is listed as a regional player.
Does adMare BioInnovations have an API?
No public API is recorded for adMare BioInnovations.
What industry is adMare BioInnovations in?
adMare BioInnovations's product category is Biotech Venture Development & Incubation. Its primary akta.pro industry code is HLAAAKAF, Process Development & Tech Transfer Services (upstream/downstream), with a secondary code of EDAEAGAI, Makerspace, Innovation Lab & Fab Lab Operations (Tools, Safety, Programming). Its NAICS code is 541714 and its SIC code is 8731.